GGrantIndex
← Leaderboards

Shayn Peirce-Cottler

University Of Virginia

$6,432,623
Attributed
$10,149,239
Total exposure
9
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $750.6K · FY200725
$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,149,239 · 9

By mechanism

R01$6,015,363 · 3
U01$2,530,185 · 1
R21$1,581,691 · 4
R13$22,000 · 1

Top collaborators

Most similar at University Of Virginia

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsSignal TransductionTissuesIn VivoBlood CapillariesResponsePericytesPhenotypeDesignBloodBlood VesselsEnvironmentChronicRetinaBaseGrowthInflammationCharacteristicsExhibitsMediatingExperimental StudyFibroblastsPublishingBehavior

Grant awards (28)

Multiscale Computational Modeling to Design Patterned Tissue Assembloids for Biomanufacturing$205,679
R21 · FY2025 · EB
Modeling to Design Treatments for Idiopathic Lung Fibrosis$537,250
R01 · FY2024 · HL · contact PI
Multiscale Computational Modeling to Design Patterned Tissue Assembloids for Biomanufacturing$169,702
R21 · FY2024 · EB
Modeling to Design Treatments for Idiopathic Lung Fibrosis$548,214
R01 · FY2023 · HL · contact PI
Modeling to design optimized estrogen-specific muscle regeneration treatment$166,526
R21 · FY2023 · AR
Modeling to Design Treatments for Idiopathic Lung Fibrosis$548,214
R01 · FY2022 · HL · contact PI
Modeling to design optimized estrogen-specific muscle regeneration treatment$202,432
R21 · FY2022 · AR
Modeling to Design Treatments for Idiopathic Lung Fibrosis$548,214
R01 · FY2021 · HL · contact PI
Multiscale Modeling for Treatment Discovery in Duchenne Muscular Dystrophy$443,243
U01 · FY2020 · AR
Multiscale Modeling for Treatment Discovery in Duchenne Muscular Dystrophy$506,257
U01 · FY2019 · AR
Modeling to Design Treatments for Vascular Pericyte Disassociation in Diabetes$236,623
R21 · FY2019 · EY · contact PI
Multiscale Modeling for Treatment Discovery in Duchenne Muscular Dystrophy$514,085
U01 · FY2018 · AR
Modeling to Design Treatments for Vascular Pericyte Disassociation in Diabetes$196,368
R21 · FY2018 · EY · contact PI
11th World Congress for Microcirculation 2018 (WCM2018)$22,000
R13 · FY2018 · HL · contact PI
Multiscale Modeling for Treatment Discovery in Duchenne Muscular Dystrophy$524,715
U01 · FY2017 · AR
Multiscale Modeling for Treatment Discovery in Duchenne Muscular Dystrophy$541,885
U01 · FY2016 · AR
Adipose Stem Cells for Diabetic Retinopathy$491,833
R01 · FY2015 · EY · contact PI
Adipose Stem Cells for Diabetic Retinopathy$491,833
R01 · FY2014 · EY · contact PI
Adipose Stem Cells for Diabetic Retinopathy$476,778
R01 · FY2013 · EY · contact PI
Adipose Stem Cells for Diabetic Retinopathy$516,372
R01 · FY2012 · EY · contact PI
Arteriole/Venule Polarity in Adult Microvasculature$364,684
R01 · FY2011 · HL · contact PI
Arteriole/Venule Polarity in Adult Microvasculature$365,225
R01 · FY2010 · HL · contact PI
Arteriole/Venule Polarity in Adult Microvasculature$365,745
R01 · FY2009 · HL · contact PI
Therapeutic Microvascular Pericytes$220,998
R21 · FY2009 · HL · contact PI
Arteriole/Venule Polarity in Adult Microvasculature$28,028
R01 · FY2009 · HL · contact PI
Arteriole/Venule Polarity in Adult Microvasculature$366,246
R01 · FY2008 · HL · contact PI
Therapeutic Microvascular Pericytes$183,363
R21 · FY2008 · HL · contact PI
Arteriole/Venule Polarity in Adult Microvasculature$366,727
R01 · FY2007 · HL · contact PI